Clin2
NCT06356233Possibly a fitNot yet recruiting

Understanding STXBP1 brain disorder in young children

STXBP1 Encephalopathy With Epilepsy

Part of Brain & nervous system, Genetic & congenital clinical trials.

This study looks at children with a confirmed STXBP1 genetic mutation to better understand the condition and find biological markers. It aims to help diagnose and treat the disease more effectively in the future.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10 people
Ages
1 month to 10 years
Study type
Observational

Who can take part

  • Your child must be under 10 years old.
  • Your child must have a confirmed STXBP1 genetic mutation.
  • If the mutation test wasn't clear, a trio exome test will be done to confirm.
  • Your child must not have a severe disability that prevents neuropsychological testing.
  • There must be a reliable person (like a parent) who can provide information about your child.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06625112Recruiting
STXBP1 disorder clinical trial readiness study

This study is for people with a confirmed STXBP1 genetic change to help prepare for future clinical trials. It collects information about the condition to better understand it.

Antwerp
NCT06555965Recruiting
STXBP1 and SYNGAP1 natural history study

This study follows people with STXBP1 or SYNGAP1 gene changes over time to learn more about how these conditions affect the body and mind. It does not test a treatment but helps researchers understand the natural course of the disorder.

Palo Alto, California
NCT01858285Recruiting
Genetics study for children with epilepsy

This study looks for genetic (inherited DNA) causes of epilepsy in children. It may help your family better understand what could be driving seizures, even if the cause isn’t known yet.

Boston, Massachusetts
NCT05419492Recruiting· Phase 1/Phase 2
ETX101 for children with SCN1A Dravet syndrome

This early-phase study tests how safe ETX101 is and whether it can help reduce seizures in young children with Dravet syndrome caused by an SCN1A gene change. It mainly enrolls infants and children with a specific type of seizure history and genetic result.

San Francisco, California
NCT07396883Not yet recruiting
New DNA test for severe epilepsy in children

This trial uses a new, more detailed DNA test (long-read sequencing) to find the cause of severe epilepsy with developmental delays in children when standard genetic testing did not provide an answer. It aims to help families understand the genetic basis of their child's condition.

Besançon
NCT02890641Recruiting
Study of brain signals and genes in hard-to-treat epilepsy

This study looks at genetic factors and brain electrical activity in children whose seizures are difficult to control with standard medicines. It also involves exams like MRI and possibly procedures under anesthesia, to better understand seizure causes and help future care.

Paris

Hear when a new STXBP1 Encephalopathy With Epilepsy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.